Please login to the form below

Not currently logged in
Email:
Password:

Huntingdon Life Sciences appoints Joseph Bedford

He will serve as the firm's corporate VP forglobal strategic marketing

Huntingdon Life Sciences Harlan Laboratories Joseph BedfordHuntingdon Life Sciences and Harlan Laboratories have appointed Joseph Bedford as corporate vice president for global strategic marketing.

The two UK research firms already share a joint management structure and will later this year be merged under a single, yet-to-be-disclosed, brand. Bedford's newly-created role will see him head up a global team of 19 staff and sit on the firm's executive leadership team.

The job spans the company's contract research services (CRS) and research models services (RMS) business units, with responsibility for global marketing, business intelligence, strategic planning and some aspects of corporate development.

Dr Adrian Hardy, chief operating officer at Huntingdon Life Sciences and Harlan Laboratories, said: “We are delighted that Joe has joined the organisation. This is an especially important time for us as we continue to develop the combined, integrated brand of the two companies.

“Joe's strong expertise in strategic marketing across both the CRS and RMS CRO space will prove to be a great asset to the organisation, and he brings an experienced new voice to the team.”

Prior to joining Huntingdon and Harlan Bedford served as vice president of global marketing at Taconic Biosciences and he had stints with Covance, most recently as director of marketing and strategy, and the Almac Group, as director of marketing, over a twelve year period.

Commenting on his new role Bedford said: “I am very pleased to take on this position and look forward to playing my part in rebranding these two market leading companies and their subsidiaries to create a dynamic new firm that is well positioned for future growth.

“This is an ideal time to join the organisation given the enormous potential of the combined entity in the marketplace. We are already seeing the benefits of bringing these businesses together - it is exciting our customers, our employees and all the stakeholders in our new company.”

28th May 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...